Sector
Pharma & Biotech

AIPPI takes the AIPPI Café live for the first time
11 September 2022Building on the success of its all-virtual AIPPI Café sessions during the Covid-19 pandemic, the International Association for the Protection of International Property launched its inaugural in-person Café set of small group discussions at the AIPPI...

Patent Attorney Gauges Ongoing Cochlear, US University Infringement Suit
16 August 2022As Australian biotech company Cochlear and the University of Pittsburgh engage in a patent infringement dispute in an American court, Dr. Simon Potter, a principal at Spruson & Ferguson in Sydney, said it will be interesting to see how the case will...

Plurality of distinct inventions: Distinct practices of India, Europe and the United States in the f...
31 May 2022Practitioners in the field of intellectual property – and more specifically in patents – are aware that patent protection is awarded to inventor(s) or applicant(s) only for a single invention or a group of closely related inventions in a patent appli...

Medical use claims in ASEAN countries
31 May 2022A method of treatment of human or animal body is either considered a non-patentable subject matter or not capable of industrial application in ASEAN countries. However, some ASEAN countries allow amendments of method of treatment claims to medical us...

TRIPS and international pressure on high-income countries to accept TRIPS waiver
30 April 2022In the wake of the ongoing Covid-19 pandemic, there is an ever-growing urgent need to supply vaccines, new medicines and testing kits, protective clothing etc. With almost 5.9 million lives lost to the Covid-19 pandemic in the last two years (as per...

Patent waiver for Covid-19 vaccines finally approved
30 June 2022The World Trade Organization (WTO) has finally approved the patent waiver that will tear down barriers mounted by intellectual property restrictions to greater production of Covid-19 vaccines and their equitable distribution among nations.